Author: Steve Kopczak

• Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.
• Durham DD, Abraham LA, Roberts MC, Khan CP, Smith RA, Kerlikowske K, Miglioretti DL.
• Cancer. 2022 Oct 19. doi: 10.1002/cncr.34365. Epub ahead of print.

• PMID: 36262035
• PubMed abstract
• Source abstract

Related:

Commentary:

What if the age at which a woman started regular mammographic screening depended on her risk, not age?

• PMID: 36262034
• PubMed abstract
• Source abstract

• Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges.
• Zhang X, Huo X, Guo H, Xue L.
• Front Pharmacol. 2022 Oct 3;13:965244. doi: 10.3389/fphar.2022.965244.

• PMID: 36263120
• PubMed abstract

• Review
• Free PMC article
• Free Full Text

• Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.
• Hoffman TL, Kershberg H, Goff J, Holmquist KJ, Haque R, Alvarado M.
• Fam Cancer. 2022 Oct 20. doi: 10.1007/s10689-022-00317-w. Epub ahead of print.

• PMID: 36261688
• PubMed abstract

• Free Full Text

• Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.
• Lu M, Liu H, Zheng B, Sun S, Chen C.
• Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117.

• Source abstract

• Review
• Free Full Text

• Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.
• O'Reilly DE, Dooley L, Watson GA, Clarke R, Nolan A, Nolan C, Berkeley E, Farrell M, McDevitt T, Rogers M, Clabby C, Gallagher DJ.
• Ir J Med Sci. 2022 Oct 19. doi: 10.1007/s11845-022-03176-7. Epub ahead of print.

• PMID: 36260241
• PubMed abstract
• Source abstract

• Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
• Sarki M, Ming C, Aceti M, Fink G, Aissaoui S, Bürki N, Graffeo R, Heinimann K, Zufferey MC, Monnerat C, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC.
• J Pers Med. 2022 Oct 19;12(10):1740. doi: 10.3390/jpm12101740.

• Source abstract

• Free Full Text

• Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.
• Cheng A, Rao Q, Liu Y, Huo C, Lin Z, Lu H.
• Gynecol Oncol. 2022 Oct 18:S0090-8258(22)01888-1. doi: 10.1016/j.ygyno.2022.10.011. Epub ahead of print.

• Source abstract

• Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.
• Lu M, Liu H, Zheng B, Sun S, Chen C.
• Cancers (Basel). 2022 Oct 19;14(20):5117. doi: 10.3390/cancers14205117.

• Source abstract

• Review
• Free Full Text

• Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.
• O'Reilly DE, Dooley L, Watson GA, Clarke R, Nolan A, Nolan C, Berkeley E, Farrell M, McDevitt T, Rogers M, Clabby C, Gallagher DJ.
• Ir J Med Sci. 2022 Oct 19. doi: 10.1007/s11845-022-03176-7. Epub ahead of print.

• PMID: 36260241
• PubMed abstract
• Source abstract

• Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
• Sarki M, Ming C, Aceti M, Fink G, Aissaoui S, Bürki N, Graffeo R, Heinimann K, Zufferey MC, Monnerat C, Rabaglio M, Zürrer-Härdi U, Chappuis PO, Katapodi MC.
• J Pers Med. 2022 Oct 19;12(10):1740. doi: 10.3390/jpm12101740.

• Source abstract

• Free Full Text

• Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.
• Cheng A, Rao Q, Liu Y, Huo C, Lin Z, Lu H.
• Gynecol Oncol. 2022 Oct 18:S0090-8258(22)01888-1. doi: 10.1016/j.ygyno.2022.10.011. Epub ahead of print.

• Source abstract